Comments: US HB1035 | 2019-2020 | 116th Congress

Bill Title: Prescription Drug Price Transparency Act

Spectrum: Slight Partisan Bill (Republican 20-12)

Status: (Introduced) 2019-02-07 - Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Oversight and Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. [HB1035 Detail]

Text: Latest bill text (Introduced) [PDF]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2019 US Congress HB1035 at this time.

Social Comments on US HB1035

feedback